Aurobindo Pharma slips after Andhra Pradesh facility gets 5 observations from USFDA
Aurobindo Pharma slumped 6.19% to Rs 1,091.95 after the United States Food and Drug Administration (USFDA) has issued five observations to Aurobindo Pharma stepdown subsidiary, Eugia Steriles' ...
Piramal Pharma declines after US FDA issues Form 483 with 6 observations to Turbhe unit
Piramal Pharma slipped 1.14% to Rs 195.40 after the US FDA issued a Form-483 with 6 observations to the company's Turbhe facility post a GMP inspection.
RFK Jr. says childhood vaccine schedule to be investigated after promising to not change it
Robert F. Kennedy Jr. vows to investigate the childhood vaccine schedule, raising concerns about his commitment to maintaining it as he promised earlier.
2 ASX 200 pharmaceutical shares surging on big US news
Big news is getting investors excited on Wednesday. Let's find out what is happening. The post 2 ASX 200 pharmaceutical ...
Piramal Pharma shares in focus after US FDA issues six observations for Mumbai facility
Piramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, ...